Skip to main content
Fig. 7 | BMC Nephrology

Fig. 7

From: COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry

Fig. 7

a: Survival at 30 days from first SARS-CoV-2 test. *Log Rank Test for KM is p < 0.001. Survival at 30 days: SARS-CoV-2 Neg: 0.91 (95% CI 0.894,0.94); SARS-CoV-2 Positive: 0.71 (95% CI 0.630, 0.802). b: Survival at 30 days from first SARS-CoV-2 Test split by modality at time of test result.

Survival at 30 days Haemodialysis:

SARS-CoV-2 Neg: 0.92 (95% CI 0.885, 0.94)

; SARS-CoV-2 Positive: 0.71 (95% CI 0.623, 0.817).

Survival at 30 days Kidney Transplant:

SARS-CoV-2 Neg: 0.94 (95% CI 0.91, 0.98)

; SARS-CoV-2 Positive: 0.71 (95% CI 0.544, 0.915)

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us